𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats

✍ Scribed by Heather A. Harris; Vargheese M. Chennathukuzhi; Xiaochun Zhang; Belew Mekonnen; Scott A. Jelinsky; Scott H. Schelling; Vikram S. Patel; Christine Huselton; Andre Negahban; Farooq Azam; Richard C. Winneker


Book ID
116698237
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
624 KB
Volume
112
Category
Article
ISSN
0960-0760

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Trace LC/MS/MS quantitation of 17Ξ²-estra
✍ Chris Petucci; Tom Lloyd; Heather A. Harris; Xiaochun Zhang; Vargheese M. Chenna πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 142 KB

## Abstract A sensitive LC/MS/MS method has been developed by derivatization of 17β‐estradiol (E2) with dansyl chloride to quantitate 17β‐E2 in female rat serum. The use of E2‐d~5~ minimized interferences from endogenous 17β‐E2 in order to achieve a limit of quantitation (LOQ) of 2.5 pg/ml using 15

Effect of the selective estrogen recepto
✍ D. Kim Swisher; Robert M. Tague; David E. Seyler πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 282 KB

Raloxifene i s a selective estrogen receptor modulator known to have antiestrogenic effects o n uterine tissue. In this study, the effects of raloxifene on uterine explant growth were evaluated in rats. Rats were ovariectomized, implanted with an estradiol pellet, and an endometriosis-like state was